Prudential Financial Inc Ab Cellera Biologics Inc. Transaction History

Prudential Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$7.31 - $11.18 $438 - $670	-60 Reduced 0.45%	13,230 $99,000
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $47 - $72	5 Added 0.04%	13,290 $0
Q3 2022 Nov 04, 2022	BUY	$9.2 - $13.68 $1,701 - $2,530	185 Added 1.41%	13,285 $131,000
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $74,932 - $139,515	13,100 New	13,100 $140,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.